Small Cap Losers: AOUT, TMDX, ATOS
3:42 pm Friday, July 16th, 2021
American Outdoor Brands, Inc. (NASDAQ:AOUT) stock slumped 21.50% to $28.23 after the company reported upside Q4 EPS on in-line revs while issuing upside FY22 guidance. Increases in both e-commerce and traditional sales channels across co’s brand lanes in connection with increased consumer interest in outdoor lifestyle activities drove sales growth. Pulls back to two-month lows after posting record highs earlier this month.
TransMedics Group Inc (NASDAQ:TMDX) touches down to one-month lows, extending recent volatility. Among recent updates, co announced yesterday that the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee convened by the FDA issued a favorable vote in support of approval of the OCS Liver System. The stock is now down 12.50% to $27.14.
Atossa Therapeutics Inc (NASDAQ:ATOS) Continued volatility on higher than average volume; the stock pulls back to one month lows, down approx. 22% through the most recent two sessions. Last week, the company announced it has received regulatory approval from HREC (Human Research Ethics Committee) to open a clinical study of AT-H201 in Australia. The nebulized formulation, AT-H201, is being developed as an inhalation therapy for moderately to severely-ill hospitalized COVID-19 patients and for “long-haul” patients with post-infection pulmonary disease.
